JUN 20, 2018 05:17 AM PDT

The Role of Estrogen Therapy in Gut Bacteria

WRITTEN BY: Nouran Amin

A recent research study on mouse models found that periodic treatment of estrogen and bazeedoxifene has affected estrogen metabolism and altered the microbial composition in the gut.

The study, which was published in the journal Scientific Reports and led by food science and human nutrition professor Zeynep Madak-Erdogan of the University of Illinois, examined the enzyme B-glucuronidase (GUS) found to have a pivotal role in synthetic estrogen metabolism of the intestinal tract. The research particularly finds that changing gut chemistry could be an effective method for long-term safe use of estrogen supplementation for postmenopausal women and breast cancer patients.

"Our findings indicate that clinicians might be able to manipulate the gut biome through probiotics to change the half-life and properties of estrogens so that long-term users obtain the therapeutic benefits of estrogen-replacement therapy without increasing their risks of reproductive cancers," says Madak-Erdogan.

Although the research needs to be replicated in humans, the study brings new answers into estrogen-replacement therapeutics on the longevity of microbial gene expression. The study also suggests how these findings can provide deeper insights on to why various patients physiologically respond differently to hormone therapy.

The study examined 40 female mice who were fed a high fat diet and had there ovaries removed to mimic estrogen-deficient physiology associated with postmenopausal women. The mice were categorized into five treatment groups that were treated with various estrogens that administered separately or in combination with the estrogen-receptor drug bazedoxifene. Investigators later isolated genomic DNA from the mice to examine gene transcription. They also examined the microbiotas of their cecum’s.

"We observed that both levels of fecal GUS activity and glucuronic acid -- a byproduct of estrogen metabolism -- decreased after the mice were treated with conjugated estrogens and bazedoxifene," Madak-Erdogan said. "This supported our hypothesis that estrogen supplementation affects the gut microbiome composition and estrogen metabolism.

"While the overall diversity of microbiota was not changed significantly, we found that the activities of several bacteria taxa were altered by the estrogen therapy," Madak-Erdogan said. "The levels of several bacteria associated with GUS activity in the gut decreased, including levels of akkermansia," a family of bacteria believed to have anti-inflammatory properties in humans.

Results showed that the fecal levels of akkermansia were reduced in mice treated with the estrogen-bazedoxifene combination compared with other mice paled in the control group. However, mice with increased levels of akkermansia, have gained weight, had larger livers and the icnreasced resence of estrogen metabolites.

Researchers also found two particular bacterial families that were dominate in the fecal microbiota: lactobacillus and streptococcus.

Source: University of Illinois at Urbana-Champaign

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 20, 2019
Cell & Molecular Biology
SEP 20, 2019
Progress on a Potential Drug for Inflammatory Disease
A team of researchers is trying to develop a treatment for chronic inflammatory disorders by inhibiting a complex called the NLRP3 inflammasome....
SEP 20, 2019
Technology
SEP 20, 2019
Nanoemulsion: The new way to deliver drugs
Nanoemulsions are tiny droplets of one liquid suspended within another liquid. These emulsions are similar to the droplets that form when you shaking an oi...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
The Composition of Cerebrospinal Fluid in MS patients Could Be The Key To Treatments That Halt Progression
The range of disability for individuals living with multiple sclerosis (MS) varies significantly depending on the relapsing/remitting form of the disease....
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Aspirin: The Good and Bad for Breast Cancer Survivors
Early research has indicated that aspirin usage may increase the survival rate among women with breast cancer. These studies were based on aspirin’s ...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Drug Targets Early Instigators of Alzheimer Disease
The two solidifying instigators of Alzheimer -disease (AD)—amyloid beta and the tau protein—have long been the topic of study for AD researcher...
SEP 20, 2019
Genetics & Genomics
SEP 20, 2019
How Epigenetics Could Cure Addiction
Addictive behavior is characterized by relapse- being triggered by environmental factors to re-engage in harmful behavior from drug abuse to self harm. One...
Loading Comments...